Literature DB >> 16306774

Bone loss in Crohn's disease: exercise as a potential countermeasure.

Naomi Lee1, Graham Radford-Smith, Dennis R Taaffe.   

Abstract

Crohn's disease (CD) is associated with a number of secondary conditions including osteoporosis, which increases the risk of bone fracture. The cause of metabolic bone disease in this population is believed to be multifactorial and may include the disease itself and associated inflammation, high-dose corticosteroid use, weight loss and malabsorption, a lack of exercise and physical activity, and an underlying genetic predisposition to bone loss. Reduced bone mineral density has been reported in between 5% to 80% of CD sufferers, although it is generally believed that approximately 40% of patients suffer from osteopenia and 15% from osteoporosis. Recent studies suggest a small but significantly increased risk of fracture compared with healthy controls and, perhaps, sufferers of other gastrointestinal disorders such as ulcerative colitis. The role of physical activity and exercise in the prevention and treatment of CD-related bone loss has received little attention, despite the benefits of specific exercises being well documented in healthy populations. This article reviews the prevalence of and risk factors for low bone mass in CD patients and examines various treatments for osteoporosis in these patients, with a particular focus on physical activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306774     DOI: 10.1097/01.mib.0000192325.28168.08

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

1.  Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission.

Authors:  Patricia D Jones; Michael D Kappelman; Christopher F Martin; Wenli Chen; Robert S Sandler; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2015-05       Impact factor: 5.325

Review 2.  Exercise and inflammatory bowel disease.

Authors:  Neeraj Narula; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

Review 3.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 4.  Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?

Authors:  Graham Radford-Smith; Nirmala Pandeya
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

5.  Colitis-induced bone loss is gender dependent and associated with increased inflammation.

Authors:  Regina Irwin; Taehyung Lee; Vincent B Young; Narayanan Parameswaran; Laura R McCabe
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

6.  Mandibular trabecular bone structure in adults with Crohn's disease.

Authors:  Grethe Jonasson; Fredrik Lindberg; Alberto Jorge; Torgny Alstad; Hossein Kashani
Journal:  Clin Oral Investig       Date:  2013-04-17       Impact factor: 3.573

Review 7.  Risk factors for osteoporosis in inflammatory bowel disease patients.

Authors:  Carla Andrade Lima; Andre Castro Lyra; Raquel Rocha; Genoile Oliveira Santana
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

8.  Body composition and muscle strength as predictors of bone mineral density in Crohn's disease.

Authors:  Naomi Lee; Graham L Radford-Smith; Mark Forwood; Joseph Wong; Dennis R Taaffe
Journal:  J Bone Miner Metab       Date:  2009-03-31       Impact factor: 2.626

9.  An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6.

Authors:  A Del Fattore; A Cappariello; M Capulli; N Rucci; M Muraca; F De Benedetti; A Teti
Journal:  Osteoporos Int       Date:  2013-08-14       Impact factor: 4.507

10.  Effect of exercise on chemically-induced colitis in adiponectin deficient mice.

Authors:  Arpit Saxena; Emma Fletcher; Bianca Larsen; Manjeshwar Shrinath Baliga; J Larry Durstine; Raja Fayad
Journal:  J Inflamm (Lond)       Date:  2012-08-21       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.